up:
Gapping up
Earnings/guidance: WGO +6.9%, NKE +2.6%
M&A news:
- INVN +16.8% (TDK Corporation to acquire INVN for $13.00/share in cash)
Select small cap oil & gas names seeing early bid: BCEI +5.8%, GST +5.3%, GTE +3.1%, SDRL +2.2%, WTI +2.0%, FRO +2.0%, LPI +1.7%, WLL +1.5%, NBR +1.5%
Other news:
- TINY +22% (light volume; announced a proposed strategic restructuring)
- CALA +18.0% (co and Bristol-Myers Squibb (BMY) announce a clinical trial collaboration to evaluate Bristol-Myers Squibb's Opdivo in combination with Calithera's CB-839 in patients with clear cell renal cell carcinoma)
- LXRX +12.6% (reports 'positive' top-line results in second pivotal phase 3 study for sotagliflozin in patients with type 1 diabetes; study met its primary endpoint)
- GLBS +7.9% (provided an update regarding its proposed $5 mln private placement and conversion of outstanding loans)
- ERJ +5.5% (creates a new business unit dedicated to services and support)
- TIG +3.3% (Takeda (TKPYY) exercises option to make a EUR 10 million equity investment)
- DEPO +2.7% (still checking)
- CBD +2.6% (still checking)
- JCP +2.8% (still checking)
- DRYS +1.7% (still checking)
- VALE +1.5% (co agreed with BHP Billiton Brasil Ltda. (BHP) and Samarco Mineração S/A (Samarco) a non-binding term sheet outlining the general terms and conditions for the use of Vale's Timbopeba pit)
Analyst actions:
- MNST +1.9% (upgraded to Buy from Hold at Jefferies)
- STO +1.9% (upgraded to Buy from Neutral at UBS)
- BP +1.1% (upgraded to Buy from Neutral at UBS)